Related Experiment Video
Updated: Mar 20, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
Arsenic silences hepatic PDK4 expression through activation of histone H3K9 methylatransferase G9a
Xi Zhang1, Jianguo Wu1, Jonathan Choiniere1
1Department of Physiology and Neurobiology and The Institute for Systems Genomics, University of Connecticut, Storrs, CT 062696, United States.
Abstract:
It is well established that increased liver cancer incidence is strongly associated with epigenetic silencing of tumor suppressor genes; the latter is contributed by the environmental exposure to arsenic. Pyruvate dehydrogenase kinase 4 (PDK4) is a mitochondrial protein that regulates the TCA cycle. However, the epigenetic mechanisms mediated by arsenic to control PDK4 expression remain elusive. In the present study, we showed that histone methyltransferase G9a- and Suv39H-mediated histone H3 lysine 9 (H3K9) methylations contributed to PDK4 silencing in hepatic cells. The PDK4 expression was induced by G9a inhibitor BRD4770 (BRD) and Suv39H inhibitor Chaetocin (CHA). In contrast, arsenic exposure decreased PDK4 expression by inducing G9a and increasing H3K9 di- and tri-methylations levels (H3K9me2/3). In addition, arsenic exposure antagonizes the effect of BRD by enhancing the enrichment of H3K9me2/3 in the PKD4 promoter. Moreover, knockdown of G9a using siRNA induced PDK4 expression in HCC cells. Furthermore, arsenic decreased hepatic PDK4 expression as well as diminished the induction of PDK4 by BRD in mouse liver and hepatocytes. Overall, the results suggest that arsenic causes aberrant repressive histone modification to silence PDK4 in both HCC cells and in mouse liver.
Insights
Arsenic exposure silences the tumor suppressor gene PDK4 in liver cells by promoting repressive histone modifications. This epigenetic silencing, mediated by G9a and Suv39H, contributes to liver cancer development.
Area of Science:
- Epigenetics
- Cancer Biology
- Environmental Toxicology
Background:
- Liver cancer incidence correlates with epigenetic silencing of tumor suppressor genes.
- Arsenic exposure is a known contributor to epigenetic alterations.
- Pyruvate dehydrogenase kinase 4 (PDK4) is a mitochondrial protein involved in the TCA cycle, but its epigenetic regulation by arsenic is unclear.
Purpose of the Study:
- To elucidate the epigenetic mechanisms by which arsenic controls PDK4 expression.
- To investigate the role of histone methyltransferases G9a and Suv39H in arsenic-mediated PDK4 silencing.
Main Methods:
- Utilized G9a inhibitor BRD4770 (BRD) and Suv39H inhibitor Chaetocin (CHA) to assess PDK4 expression.
- Measured histone H3 lysine 9 (H3K9) di- and tri-methylations (H3K9me2/3) levels.
- Employed siRNA to knock down G9a in hepatocellular carcinoma (HCC) cells.
- Exposed mouse liver and hepatocytes to arsenic.
Main Results:
- Histone methyltransferases G9a and Suv39H contribute to PDK4 silencing via H3K9 methylation.
- Arsenic exposure decreased PDK4 expression by inducing G9a and increasing H3K9me2/3 levels.
- Arsenic enhanced H3K9me2/3 enrichment at the PKD4 promoter, counteracting BRD's effect.
- G9a knockdown and arsenic exposure reduced hepatic PDK4 expression in mice and hepatocytes.
Conclusions:
- Arsenic exposure silences PDK4 expression in hepatic cells and mouse liver through aberrant repressive histone modifications.
- The findings suggest a mechanism linking environmental arsenic exposure to liver cancer via epigenetic silencing of PDK4.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Inhibition of Cdk Activity
The JAK-STAT Signaling Pathway
Abnormal Proliferation
Cell Specific Gene Expression

